جست‌وجوی استاد و پژوهشگر

Massimiliano Di Ventraمشاهده پروفایل

استاد

• Quantum transport
• Non-equilibrium statistical mechanics
• DNA sequencing
• +۶ مورد دیگر

Massimiliano Di Ventra is a Professor of Physics at the University of California, San Diego, holding this position since 2006 after serving as Associate Professor (2004-2006) and moving from Virginia Tech where he was Assistant Professor (2000-2002) and Associate Professor (2003). His academic journey includes research roles at IBM T.J. Watson Research Center and Vanderbilt University. Education: Undergraduate degree in Physics, summa cum laude, University of Trieste, Italy (1991) PhD in Physics, Swiss Federal Institute of Technology, Lausanne (1993-1997) Di Ventra's research bridges theoretical physics with practical applications, focusing on quantum transport in nanoscale systems, non-equilibrium statistical mechanics, and DNA sequencing/polymer dynamics in nanopores. His pioneering work on memory effects in nanostructures has driven innovations in unconventional computing and biophysics, resulting in over 300 refereed publications and significant commercial impact through memcomputing technologies. His scientific awards include: Senior member, National Academy of Inventors (2025) Humboldt Research Award (2024) Fellow, American Association for the Advancement of Science (2022) IEEE Nanotechnology Council Distinguished Lecturer (2022) Fellow, IEEE (2022) George W. and Carol A. Lattimer Research Fellow (2021) Member of Academia Europaea (2020) Feynman Prize for Theory in Nanotechnology (2020) APS Outstanding Referee (2019) Highly Cited Researcher (2018) Di Ventra has secured major research funding including an NSF CAREER Award and Ralph E. Powe Award, holds 11 granted patents, and co-founded MemComputing, Inc. His mentorship extends to numerous graduate students and postdoctoral researchers within his active research group at UCSD. He maintains a globally recognized research presence through visiting professorships at institutions including École Normale Supérieure of Paris (2024), Technion (2017), and Technical University of Dresden (2015), and has delivered over 350 invited talks including 20 plenary/keynote presentations worldwide.

Joshua Gessمشاهده پروفایل

دانشیار

• Thermal management
• Heat transfer
• Microelectronic cooling
• +۵ مورد دیگر

Joshua Gess is an Associate Professor in the Mechanical, Industrial, and Manufacturing Engineering department at Oregon State University's College of Engineering. He joined Oregon State in 2015 and serves as a co-principal investigator at the Enhanced Heat Transfer Laboratory, where he leads research in thermal management solutions for high-performance microelectronics. His educational background includes: PhD, Mechanical Engineering, Auburn University, 2015 MS, Mechanical Engineering, Auburn University, 2012 B.E., Mechanical Engineering, Vanderbilt University, 2005 Before academia, he worked as a mechanical engineer at SSOE Group (including consulting for Johns Manville) and Northrop Grumman where he focused on military communication equipment. Professor Gess specializes in advancing thermal management solutions for high-performance microelectronic equipment. His research spans multiple scales, examining single and two-phase heat transfer on the macro-scale with passive and active liquid immersion techniques, as well as on the micro and nano scale for complex embedded thermal management solutions. He combines fundamental heat transfer knowledge with novel experimental methods such as two-phase PIV and high-speed image capture to develop reliable and energy-efficient cooling solutions for demanding electronics systems. His publication record demonstrates a clear trajectory toward increasingly sophisticated thermal management solutions, with recent work focusing on additive manufacturing applications for cooling systems, semiconductor thermal management, and nuclear reactor cooling systems. His research has significant implications for data center energy efficiency, where even small improvements in cooling efficiency could save enormous amounts of energy that could be returned to the grid. Gess is deeply committed to mentoring graduate students, emphasizing the practical applications of engineering principles. He attributes his interest in engineering to childhood influences like the movie RoboCop and the TV series MacGyver, and finds the reality of engineering work just as gratifying as he'd imagined. He particularly values the moments when his graduate students "get it" and watching them grow with each new accomplishment. As a person with a disability himself, Gess is passionate about establishing more robust support systems for people with disabilities at Oregon State. He is working with the School of Public Health to start an adaptive sports program, with the goal of building infrastructure that allows anyone to feel welcome and pursue advanced degrees at the university.

Angel Xuan Changمشاهده پروفایل

دانشیار

• Natural language processing
• 3D scene understanding
• Multimodal grounding of language
• +۵ مورد دیگر

Angel Xuan Chang is an Associate Professor at Simon Fraser University's School of Computing Science, where she leads research at the intersection of natural language processing, computer vision, and 3D scene understanding. She holds the prestigious Canada CIFAR AI Chair position and is affiliated with multiple research groups including 3DLG, GrUVi, SFU NatLang, SFU AI/ML, and VINCI. PhD in Computer Science, Stanford University MSc in Computer Science, Stanford University M.Eng in Electrical Engineering and Computer Science, MIT BSc in Computer Science and Engineering, MIT Professor Chang's research primarily focuses on connecting language to 3D representations of shapes and scenes, with particular emphasis on grounding language for embodied agents in indoor environments. Her work spans natural language processing and understanding, linking natural language with visual and 3D representations, multimodal grounding of language, embodied AI, and machine learning applications for biodiversity monitoring through the BIOSCAN project. She has developed methods for synthesizing 3D scenes and shapes from natural language and created various datasets for 3D scene understanding. Her recent publications reveal a strong trend toward integrating language understanding with 3D scene generation and manipulation, with increasing focus on practical applications in embodied AI and biodiversity monitoring. The research shows progression from foundational work on text-to-3D scene generation to more sophisticated approaches for evaluating semantic coherence in generated scenes and developing efficient methods for zero-shot scene modeling. Canada CIFAR AI Chair TUM-IAS Hans Fischer Fellow (2018-2022) Best paper award at 3DV 2025 for 'An Object is Worth 64x64 Pixels: Generating 3D Object via Image Diffusion' Professor Chang actively advises numerous graduate students who appear as first authors on her publications, indicating a strong mentoring program. Her research is supported through multiple channels including the CIFAR AI Chair position and likely various research grants supporting her BIOSCAN-related work and 3D scene understanding projects. She has been involved in organizing multiple workshops at major conferences including ICML, CVPR, and ICLR. Her research is conducted through several interconnected groups: 3DLG (3D Language and Graphics), GrUVi (Graphics, Vision, and Interaction), SFU NatLang (Natural Language Processing), SFU AI/ML, and VINCI. These groups work collaboratively on problems spanning language grounding, 3D scene understanding, embodied AI, and biodiversity applications, creating a rich interdisciplinary research environment.

Michael Baymمشاهده پروفایل

دانشیار

• Microbial Evolutionary Genomics
• Antibiotic Resistance
• Computational Biology
• +۷ مورد دیگر

Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .

• Immunology
• Virology
• Inflammation
• +۵ مورد دیگر

Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.

Ashis K. Patraمشاهده پروفایل

استاد

• Inorganic Chemistry
• Bioinorganic Chemistry
• Therapeutic Applications of Metal Complexes
• +۳ مورد دیگر

Ashis K. Patra is a full-time Professor in the Department of Chemistry at the Indian Institute of Technology Kanpur (IIT Kanpur). After obtaining his Ph.D. from the Indian Institute of Science (IISc) Bangalore in 2008, he carried out post-doctoral research at Harvard University and the University of Georgia before joining IIT Kanpur in 2012. Education & Academic Training Ph.D. (2008), Indian Institute of Science (IISc), Bangalore M.Sc. (2002), The University of Burdwan Research Interests Professor Patra leads an interdisciplinary program that sits at the interface of inorganic chemistry, chemical biology, and medicinal chemistry. His work is organized into three principal thrusts: Therapeutic Applications of Metal Complexes: Design and mechanistic evaluation of cytotoxic transition-metal complexes that target nucleic acids and proteins, aiming to overcome multidrug resistance in cancer. Nitric Oxide Delivery from Transition Metal Nitrosyls: Development of photo- and redox-triggered metal nitrosyl complexes for controlled NO release to biological targets such as hemoglobin, myoglobin, and glutathione. Luminescent Lanthanide Complexes: Synthesis and photophysical characterization of Eu(III) and Tb(III) complexes that serve as luminescent probes and theranostic agents. Research Output & Impact His group has published extensively in leading journals including Dalton Transactions , Inorganic Chemistry , Chemical Science , and Journal of Inorganic Biochemistry . The collective work demonstrates a clear trajectory from fundamental coordination chemistry to translational applications in drug delivery and bioimaging, with recurring themes of redox control, light activation, and biological targeting. Scientific Awards & Fellowships CSIR Junior & Senior Research Fellowships (2001, 2003) West Bengal SLET Qualification (2001) International Travel Grants from CSIR & INSA (2006) DST Fast-Track Fellowship for Young Scientists (2013) Erasmus Mundus NAMASTE Scholarship for Academic Staff (2014) JSPS Invitation Fellowship (2016) Teaching & Mentoring Professor Patra teaches core and advanced courses in inorganic chemistry, including Inorganic Chemistry Laboratory, Bioinorganic Chemistry, and Frontiers in Inorganic Chemistry. He actively mentors Ph.D. and master’s students (full list available on his lab website ) and has established the Laboratory of Inorganic Chemical Biology in the Old Core Lab complex at IIT Kanpur.

• Cancer Biology
• Mathematical and Computational Modeling
• Bioinformatics
• +۷ مورد دیگر

Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.

Ana Damjanovicمشاهده پروفایل

استاد پژوهشی

• Ion Channels
• Protein Electrostatics
• Membrane Electrostatics
• +۳ مورد دیگر

Ana Damjanovic is an Assistant Research Professor in the Thomas C. Jenkins Department of Biophysics at Johns Hopkins University (JHU), affiliated with the Zanvyl Krieger School of Arts & Sciences. Her research focuses on ion channels, protein and membrane electrostatics, and computational biophysics. She holds a Ph.D. in Physics from the University of Illinois at Urbana-Champaign, where she studied quantum physics of photosynthetic light harvesting under Prof. Klaus Schulten. Subsequent postdoctoral research included work on photosynthesis with Prof. Graham Fleming at UC Berkeley, and molecular dynamics studies of protein ionization at JHU. Her current lab investigates ion channel mechanisms, protonation dynamics, and electrostatic effects in biological systems using advanced computational tools. Group members include graduate student Nauman Sultan (co-supervised with NIH's Bernard Brooks) and undergraduates Marianne Ri and Vivek Booshan. Past advisees include Ada Chen (now a NIH postdoc) and Maggie Li. Key research contributions include developing pH replica exchange methods, protein pKa prediction using machine learning, and structural-functional studies of voltage-gated sodium channels. Her work has been published in high-impact journals like Proceedings of the National Academy of Sciences and Biophysical Journal . Lab affiliations include the Computational Biophysics Group at JHU, with access to cutting-edge simulation techniques and experimental validation platforms. Ongoing projects explore ion channel selectivity, membrane protein dynamics, and computational modeling of protonation-dependent phenomena.

Colin Sempleمشاهده پروفایل

استاد

• Cancer genomics
• Structural mutations
• Molecular evolution
• +۵ مورد دیگر

Professor Colin Semple is a leading researcher at the University of Edinburgh's Institute of Genetics and Cancer (IGC), where he serves as Group Leader and Head of Bioinformatics. His work is conducted within the MRC Human Genetics Unit, focusing on computational genomics and the analysis of structural mutations in both germline and cancer contexts. Professor Semple's research investigates the origins and impacts of structural mutations in the human genome, with particular emphasis on how these alterations affect gene function in developmental contexts and drive cancer progression. His group studies complex structural rearrangements in challenging cancer types including ovarian cancer, glioblastoma, and mesothelioma, where tumor genomes undergo dramatic reorganization. The research is guided by four key questions: What are the origins of structural mutations? How do they impact gene function? How does structural complexity drive disease progression? How do diverse mutational constellations combine to create adaptations and vulnerabilities? Analysis of Professor Semple's publications reveals a consistent focus on structural variation in cancer genomics, with particular attention to ovarian cancer mechanisms, lesion segregation in tumor evolution, and the functional consequences of genomic rearrangements. His work frequently employs whole genome sequencing approaches to uncover previously hidden layers of genomic variation that affect more of the genome than traditional short variants. Professor Semple leads a substantial research team including bioinformaticians and PhD students, and oversees the Bioinformatics Analysis Core which provides collaborative expertise to over 500 researchers at the IGC. His group maintains strong collaborations with both local researchers at the University of Edinburgh and international consortia, working closely with clinicians to translate genomic findings into potential diagnostic and therapeutic approaches. The Semple Lab is funded by major organizations including the Medical Research Council (MRC), Cancer Research UK (CRUK), and the Chief Scientist Office (CSO).

Gabriele Schweikertمشاهده پروفایل

مدرس ارشد

• Computational Biology
• Machine Learning
• Epigenetics
• +۶ مورد دیگر

Dr. Gabriele Schweikert is a Senior Lecturer and Principal Investigator with a joint appointment between the Division of Computational Biology in the School of Life Sciences at University of Dundee and Cyber Valley in Tuebingen. Her research focuses on applying machine learning techniques to understand epigenetic mechanisms and molecular processes in living cells. Dr. Schweikert completed her PhD at the Max Planck Institute Tuebingen working with Schoelkopf, Weigel, and Raetsch labs on machine learning for computational gene finding. She subsequently joined Adrian Bird's lab at the Wellcome Trust Center for Cell Biology in Edinburgh, a pioneer in epigenomic research. Prior to her current position, she held prestigious Marie Curie and EMBO Fellowships at the School of Informatics, University of Edinburgh. Her research interests center on using machine learning to decode epigenetic mechanisms that determine cellular identity and function. She investigates how cells with identical DNA can differentiate into specialized cell types through epigenetic regulation, with particular focus on applications in understanding tumorigenesis where epigenetic machinery malfunctions. Her work combines high-throughput epigenomic data with advanced computational approaches to address complex biological questions. Analysis of her recent publications reveals a strong focus on epigenomic data analysis, machine learning applications in biology, and computational approaches to understanding gene regulation. Her work spans from fundamental epigenetic mechanisms to practical applications in disease research, with growing emphasis on individual-specific epigenomic analysis and explainable AI in biomedical contexts. UKRI Future Leaders Fellowship (2020, £1.6 million) Marie Curie Fellowship EMBO Fellowship Dr. Schweikert actively supervises PhD students and has received significant research funding for projects including 'Machine Learning Methods to Re-Annotate Histone Modifications,' 'Unlocking The Alternative Splicing Code,' and 'GPU-Based Machine Learning System For Fundamental Biological Research.' She is involved in multiple interdisciplinary collaborations and frequently presents her work at major conferences including ELLIS Health program retreat, Epigenetics Meetings, and RECOMB workshops. She maintains active research laboratories in both Dundee and Tuebingen, fostering international collaboration between computational biologists, machine learning experts, and experimental biologists to advance our understanding of epigenetic regulation in health and disease.

Rahul Sarpeshkarمشاهده پروفایل

استاد

• Analog synthetic biology
• Quantum circuit design
• Feedback control systems
• +۶ مورد دیگر

Rahul Sarpeshkar is a Professor of Engineering, Microbiology & Immunology, Physics, and Molecular & Systems Biology at Dartmouth College, holding the Thomas E. Kurtz Professorship and chairing the Neukom Computational Science Cluster. His research bridges analog circuits with quantum physics, synthetic biology, and ultra-low-power systems. BS in Electrical Engineering and Physics from MIT (1995) PhD in Computation and Neural Systems from Caltech (1998) His research focuses on analog synthetic biology , quantum circuit design , and bio-inspired supercomputing , emphasizing noise, thermodynamics, and energy efficiency. He develops cytomorphic chips to model biochemical networks and quantum-inspired circuits for spectrum analysis. Recent work integrates quantum and classical computation for biological simulations, drug cocktail formulation , and ATP energy measurement in living cells. Patents highlight innovations in quantum emulation and medical devices. Scientific awards include: Fellow, National Academy of Inventors (2018) IEEE Fellow (2018) NSF CAREER Award ONR Young Investigator Award Packard Fellow Award Junior Bose Teaching Award, MIT He leads a wet lab for synthetic microbial circuit implementation and a dry lab for quantum and nanoelectronics, mentoring a multidisciplinary team of physicists, bioengineers, and computer scientists.

Celeste Saguiمشاهده پروفایل

استاد

• Computational Biophysics
• Biomolecular Simulations
• Free Energy Methods
• +۵ مورد دیگر

Celeste Sagui is a Professor in the Department of Physics at North Carolina State University (NC State), affiliated with the College of Sciences. She holds additional roles as a faculty affiliate in Genomics Sciences at NC State and is a member of the Center for High Performance Simulation. Her research focuses on computational biophysics, biomolecular simulations, and free energy methods applied to nucleic acid structures, protein dynamics, and nanotechnology systems. She has contributed to the AMBER simulation package development, co-authoring versions from 10 to 14. Education: Doctorate in Physics, University of Toronto (1995) Licentiate degree, National University of San Luis, Argentina Research Interests: Sagui’s work explores DNA/RNA structure and phase transitions, electrostatic interactions, and methodologies for large-scale molecular simulations. Recent studies include nucleic acid hairpin instabilities linked to neurodegenerative diseases, polyglutamine aggregation mechanisms, and novel DNA motifs like the eGZ structure in Z-DNA. She employs quantum chemistry, density functional theory, and phase-field models to investigate systems ranging from biomolecules to nanomaterials. Publications: Her recent work emphasizes nucleic acid dynamics, free energy landscapes, and computational methods for studying diseases such as Friedreich’s ataxia and polyglutamine disorders. Key contributions include advancements in laser-driven simulations and infrared spectroscopy analysis of protein structures. Labs/Teams: Active in the Center for High Performance Simulation, focusing on high-throughput computational modeling and collaborative software development for biomolecular research.

Raphael Franziniمشاهده پروفایل

دانشیار

• Drug Discovery
• Medicinal Chemistry
• Bioorthogonal Chemistry
• +۳ مورد دیگر

Raphael Franzini serves as Associate Professor of Medicinal Chemistry at the University of Utah, actively contributing to the Biological Chemistry PhD Program. His research pioneers innovative chemical approaches for therapeutic development, with dual focus on DNA-encoded library technologies and bioorthogonal drug delivery systems. His educational foundation includes an M.S. from the Swiss Federal Institute of Technology (Lausanne) and a Ph.D. from Stanford University. This training underpins his group's multidisciplinary methodology combining organic synthesis, bioconjugation, computational modeling, and advanced imaging techniques. Dr. Franzini's research program centers on two transformative areas: First, advancing DNA-encoded library screening through computational integration to identify leads for challenging targets like Tankyrase and Sirtuin 6, with recent work addressing false negatives in machine learning prediction. Second, developing novel bioorthogonal release chemistry using isonitrile-tetrazine reactions for spatiotemporally controlled drug activation, validated in zebrafish models. His group emphasizes both technological innovation and therapeutic translation, with chemistry designed to minimize off-target effects in solid tumors. Analysis of his 15 most recent publications reveals escalating integration of computational methods with experimental library screening, alongside refinement of bioorthogonal release kinetics. The work spans chemical biology, medicinal chemistry, and pharmaceutical sciences, with growing emphasis on machine learning for library data interpretation and in vivo validation of drug-release systems. Dr. Franzini maintains an active research laboratory that provides comprehensive training in cutting-edge drug discovery methodologies. His group culture prioritizes both scientific innovation and researcher development, with projects spanning from fundamental reaction kinetics to therapeutic applications. The lab's infrastructure supports organic synthesis, molecular imaging, and computational analysis for advancing precision therapeutics.

• Machine Learning
• Bioinformatics
• Deep Generative Models
• +۳ مورد دیگر

Anders Krogh is a Professor at the Department of Computer Science, University of Copenhagen, and also holds a position at the Department of Public Health in the Section for Health Data Science and AI. He serves as the head of the Center for Health Data Science (HeaDS) in the Faculty of Health and Medical Sciences. Previously, he was affiliated with the Department of Biology at the University of Copenhagen until 2020. Dr. Krogh earned his PhD in theoretical physics but transitioned into machine learning and bioinformatics during his doctoral studies. His research spans both theoretical foundations and practical applications in these fields. He is particularly renowned for his pioneering work on hidden Markov models for biological sequences, which has had significant impact in computational biology. In recent years, Krogh's research has focused on deep generative models applied to gene expression data and other biomedical applications. His work bridges computer science with healthcare, developing AI-driven approaches for precision medicine, cancer diagnostics, and analysis of complex biological systems. His current research integrates machine learning with quantum computing applications in biomolecular modeling. Analysis of his recent publications reveals a strong trend toward applying artificial intelligence to healthcare challenges, particularly in rare diseases, cancer diagnostics, and personalized medicine. His work increasingly incorporates federated learning approaches to address privacy concerns while enabling collaborative research across institutions. There's also a growing emphasis on quantum computing applications in biomolecular modeling and drug discovery. As head of the Center for Health Data Science, Krogh leads interdisciplinary research efforts that bring together computer scientists, medical researchers, and clinicians. His team develops novel computational frameworks like MOSAIC for multimodal analysis of rare cancers and multiDGD for multi-omics data integration. These tools are designed to translate AI innovations into clinical practice while addressing the unique challenges of medical data.

Peter A. Jonesمشاهده پروفایل

استاد

• Epigenetics
• DNA methylation
• Cancer epigenetics
• +۷ مورد دیگر

Peter A. Jones is President and Chief Scientific Officer at the Van Andel Institute (VAI) in Grand Rapids, Michigan, where he leads the Department of Epigenetics. He previously served as Director of the USC Norris Comprehensive Cancer Center from 1993 to 2011 and has been a central figure in advancing epigenetics research, particularly in cancer. His laboratory investigates DNA methylation, chromatin dynamics, and epigenetic therapies. Research Interests: Dr. Jones's work centers on epigenetic mechanisms in cancer, including DNA methylation, histone modifications, nucleosome positioning, and the therapeutic potential of epigenetic drugs. His research has pioneered the use of DNA methylation inhibitors like 5-azacytidine and explored viral mimicry as a mechanism for immune activation in cancer. He also studies transposable elements and their role in gene regulation and immune response. Publication Trends: His recent publications (2021–2024) reveal a strong focus on the interplay between epigenetics and immunotherapy, particularly how DNA methyltransferase inhibitors (DNMTi) induce viral mimicry, enhance immune recognition, and improve responses to checkpoint blockade. Studies span hematological malignancies, solid tumors, and T cell biology, with frequent collaboration with Stephen Baylin and others. Scientific Awards: Member, National Academy of Sciences Member, National Academy of Medicine Fellow, AACR Academy Fellow, AAAS Fellow, American Academy of Arts and Sciences Kirk A. Landon Award for Basic Cancer Research (2009) Medal of Honor, American Cancer Society (2011) Outstanding Investigator Grant, NCI Harvey Prize (2024) Advising and Grants: Dr. Jones mentors multiple postdoctoral fellows, graduate students, and research scientists. His lab is supported by major grants, including the VAI-SU2C Epigenetics Dream Team, which has launched 15 clinical trials. He has received sustained funding from the National Cancer Institute and collaborates with institutions worldwide to advance epigenetic therapies. Labs and Teams: He leads the Peter Jones Laboratory at VAI, a multidisciplinary team investigating epigenetic regulation in cancer. The lab includes computational biologists, clinical researchers, and molecular biologists, working on both basic mechanisms and translational applications. The team is part of larger collaborative initiatives such as the VAI-SU2C Epigenetics Dream Team and the International Linked Clinical Trials Program.